WFH 2025: Safety and Efficacy of HMB-001 as a Prophylactic Treatment of Glanzmann Thrombasthenia: Interim Analysis of Phase 1/2 Study
Presented at WFH 2025 Comprehensive Care Summit: New Developments in Bleeding Disorders and MSK
To view the presentation, click here